Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients: Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 5, 2007, Pages 521-528

  Valerio, Antonella ^a   Tronconi, Elisa ^a   Mazza, Francesca ^a   Fantoni, Giovanna ^a   Atzori, Chiara ^a   Tartarone, Federica ^a   Duca, Piergiorgio ^b   Cargnel, Antonietta ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Dihydropteroate synthase gene mutations; Genotyping; HIV AIDS; Internal transcribed spacer region; Pneumocystis jiroveci pneumonia

Indexed keywords

DIHYDROPTEROATE SYNTHASE; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 2; LACTATE DEHYDROGENASE; SULFAMETHOXAZOLE; SULFANILAMIDE; SULFONE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIHYDROPTEROATE SYNTHASE GENE; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; GENE; GENE LOCUS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTUBATION; ITALY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS ISOLATION;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DIHYDROPTEROATE SYNTHASE; DISEASE PROGRESSION; DNA, INTERGENIC; FEMALE; GENES, VIRAL; HIV; HUMANS; ITALY; MALE; MIDDLE AGED; MUTATION; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SPECIES SPECIFICITY; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VIRAL PROTEINS;

EID: 34548056102     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3180decbe2     Document Type: Article

References (38)

1. Wakefield AE. Pneumocystis carinii. Br Med Bull. 2002;61:175-188.
2. Morris A, Beard CB, Huang L. Update on the epidemiology and transmission of Pneumocystis carinii. Microbes Infect. 2002;4:95-103.
3. Helweg-Larsen J, Lee CH, Jin S, et al. Clinical correlation of variations in the internal transcribed spacers regions of rRNA genes in Pneumocystis carinii f. sp. hominis. AIDS. 2001;15:451-459.
4. Miller RF, Wakefield AE. Pneumocystis carinii genotypes and severity of pneumonia. Lancet. 1999;353:2039-2040.
5. Beard CB, Carter JL, Keely SP, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis. 2000;6:265-272.
6. Helweg-Larsen J, Tsolaki AG, Miller RF, et al. Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. QJM. 1998;91:813-820.
7. Latouche S, Ortona E, Mazars E, et al. Biodiversity of Pneumocystis carinii hominis: typing with different DNA regions. J Clin Microbiol. 1997;53:383-387.
8. Hauser PM, Francioli P, Bille J, et al. Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions. J Clin Microbiol. 1997;35:3086-3091.
9. Latouche S, Poirot JL, Bernard C, et al. Study of internal transcribed spacers and mitochondrial large-subunit genes of P. carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia. J Clin Microbiol. 1997;35:1687-1690.
10. Lu JJ, Bartlett MS, Smith JW, et al. Typing of Pneumocystis carinii strains with type-specific oligonucleotide probes derived from nucleotide sequences of internal transcribed spacers of rRNA genes. J Clin Microbiol. 1995;33:2973-2977.
11. Tsolaki AG, Miller RF, Underwood AP, et al. Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia. J Infect Dis. 1996;174:141-156.
12. Tsolaki AG, Beckers P, Wakefield AE. Pre-AIDS era isolates of Pneumocystis carinii f. sp. hominis: high genotypic similarity with contemporary isolates. J Clin Microbiol. 1998;36:90-93.
13. Lee CH, Helweg-Larsen J, Tang X, et al. Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol. 1998;36:734-741.
14. Nimri LF, Moura INS, Huang L, et al. Genetic diversity of Pneumocystis carinii f. sp. hominis based on variations in nucleotide sequences of internal transcribed spacers of rRNA genes. J Clin Microbiol. 2002;40:1146-1151.
15. Robberts FJL, Liebowitz LD, Chalkley LJ. Genotyping and coalescent phylogenetic analysis of Pneumocystis jirovecii from South Africa. J Clin Microbiol. 2004;42:1505-1510.
16. Matos O, Lee CH, Jin S, et al. Pneumocystis jirovecii in Portuguese immuno-compromised patients: association of specific ITS genotypes with treatment failure, bad clinical outcome and childhood. Infect Genet Evol. 2003;3:281-285.
17. Sepkowitz KA. Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet. 1998;351:228-230.
18. Mermin J. A family-based approach to preventive care and antiretroviral therapy in Africa [oral abstract 2]. Presented at: 12th Conference on Retroviruses and Opportunistic Infections; 2005; Boston.
19. Achari A, Somers DO, Champness JN, et al. Crystal structure of the antibacterial sulfonamide drug target dihydropteroate synthase gene. Nat Struct Biol. 1997;4:490-497.
20. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-8):1-52.
21. Walzer PD, Foy J, Steele P, et al. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1992;36:1935-1942.
22. Kazanjian P, Armstrong W, Hossler PA, et al. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis. 2000;82:551-557.
23. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, et al. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet. 1999;354:1347-1351.
24. Lane BR, Ast JC, Hossler PA, et al. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis. 1997;175:482-485.
25. Ma L, Borio L, Masur H, et al. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis. 1999;180:1969-1978.
26. Mei Q, Gurunathan S, Masur H, et al. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene. Lancet. 1998;351:1631-1632.
27. Kazanjian P, Locke AB, Hossler PA, et al. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS. 1998;12:873-878.
28. Helweg-Larsen J, Eugen-Olsen J, Lundgren B. Rapid detection of dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restriction fragment length polymorphism. Scand J Infect Dis. 2000;32:481-483.
29. Ma L, Kovacs JA, Cargnel A, et al. Mutations in dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis. 2002;185:1530-1532.
30. Nahimana A, Rabodonirina M, Zanetti G, et al. Association between a specific Pneumocystis jirovecii dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. J Infect Dis. 2003;188:1017-1023.
31. Costa MC, Helweg-Larsen J, Lundgren B, et al. Mutatons in dihydropteroate synthase gene of Pneumocystis jirovecii isolates from Portuguese patients with Pneumocystis pneumonia. Int J Antimicrob Agents. 2003;22:516-520.
32. Huang L, Beard CB, Creasman J, et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis. 2000;182:1192-1198.
33. Takahashi T, Hosoya N, Endo T, et al. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol. 2000;38:3161-3164.
34. Visconti E, Ortona E, Mencarini P, et al. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 2001;18:547-551.
35. Totet A, Duwat H, Magois E, et al. Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection. Microbiol. 2004;150:1173-1178.
36. Meshnick SR, Hossler PA, Enger KS, et al. Distribution of DHPS mutations among ITS subtypes of P. carinii f. sp. hominis. J Eukaryot Microbiol. 2001;(Suppl):126S-128S.
37. Huang L, Crothers K, Atzori C, et al. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg Infect Dis. 2004;10:1721-1728.
38. Crothers K, Beard CB, Turner J, et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS. 2005;19:801-805.